Publications by authors named "Finja Schweitzer"

Claim this Profile
S
Serum neurofilament light chain as a biomarker of disease control in multiple sclerosis: a real-world cross-sectional analysis of therapeutic regimens.
Agni M Konitsioti, Finja Schweitzer, Wibke Johannis, Falk Steffen, Stefan Bittner

J Neurol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome.
Ann-Katrin Schild, Daniel Scharfenberg, Anton Regorius, Kim Klein, Lukas Kirchner, Finja Schweitzer

Eur Arch Psychiatry Clin Neurosci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of JC polyomavirus in stool samples of patients with multiple sclerosis despite high anti-JCV antibodies in serum.
Finja Schweitzer, Anne Ladwig, Sarah Opala, Sarah Laurent, Michael Schroeter

Mult Scler Relat Disord· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN).
Alina Sprenger-Svačina, Ines Klein, Martin K R Svačina, Ilja Bobylev, Felix Kohle, Finja Schweitzer

J Neuroimmune Pharmacol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage.
Fabian Boesl, Yasemin Goereci, Finja Schweitzer, Carsten Finke, Ann-Katrin Schild

Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effects of intravenous and subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: An observational study.
Martin K R Svačina, Anika Meißner, Finja Schweitzer, Anne Ladwig, Kalliopi Pitarokoili

Eur J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.
Fabian Boesl, Yasemin Goereci, Ameli Gerhard, Benno Bremer, Vanessa Raeder, Finja Schweitzer

J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive Multifocal Leukoencephalopathy: Pathogenesis, Diagnostic Tools, and Potential Biomarkers of Response to Therapy.
Finja Schweitzer, Sarah Laurent, Irene Cortese, Gereon R Fink, Steffi Silling

Neurology· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive Allogeneic T-Cell Therapy Improves the Clinical Outcome of JC Virus Granule Cell Neuronopathy: A Case Report.
Lea Grote-Levi, Nora Möhn, Agnes Bonifacius, Sabine Tischer-Zimmermann, Finja Schweitzer

Neurol Neuroimmunol Neuroinflamm· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study.
Martin K R Svačina, Anika Meißner, Finja Schweitzer, Alina Sprenger-Svačina, Ines Klein

J Neuroimmune Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
Ann-Katrin Schild, Yasemin Goereci, Daniel Scharfenberg, Kim Klein, Joachim Lülling, Finja Schweitzer

J Neurol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome.
Christiana Franke, Fabian Boesl, Yasemin Goereci, Ameli Gerhard, Finja Schweitzer

Brain Behav Immun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A therapeutic vaccine strategy to prevent pneumonia in an immunocompromised host in a non-human primate model of HIV and co-infection.
Whitney Rabacal, Finja Schweitzer, Heather M Kling, Lizabeth Buzzelli, Emily Rayens

Front Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody response after COVID-19 vaccination in intravenous immunoglobulin-treated immune neuropathies.
Martin K R Svačina, Anika Meißner, Finja Schweitzer, Anne Ladwig, Alina Sprenger-Svačina

Eur J Neurol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal Fluid Analysis Post-COVID-19 Is Not Suggestive of Persistent Central Nervous System Infection.
Finja Schweitzer, Yasemin Goereci, Christiana Franke, Steffi Silling, Fabian Bösl

Ann Neurol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis.
Finja Schweitzer, Nina N Kleineberg, Yasemin Göreci, Oezguer A Onur, Christiana Franke

Curr Opin Neurol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of neurological symptoms and complications of COVID-19.
Xiangliang Chen, Sarah Laurent, Oezguer A Onur, Nina N Kleineberg, Gereon R Fink, Finja Schweitzer

J Neurol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin treatment prevents the development of pulmonary arterial hypertension in a nonhuman primate model of HIV-associated PAH.
Whitney Rabacal, Finja Schweitzer, Emily Rayens, Rebecca Tarantelli, Patrick Whang

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age and the risks of high-efficacy disease modifying drugs in multiple sclerosis.
Finja Schweitzer, Sarah Laurent, Gereon R Fink, Michael H Barnett, Stephen Reddel

Curr Opin Neurol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte and Alveolar Macrophage Skewing Is Associated with the Development of Pulmonary Arterial Hypertension in a Primate Model of HIV Infection.
Finja Schweitzer, Rebecca Tarantelli, Emily Rayens, Heather M Kling, Joshua T Mattila

AIDS Res Hum Retroviruses· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Evaluation of Pulmonary Arterial Hypertension in a Rhesus Macaque () Model of HIV Infection.
Rebecca A Tarantelli, Finja Schweitzer, Marc A Simon, Rebecca R Vanderpool, Ian Christman

Comp Med· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal comparison of HIV-1 plasma viral load and cellular proviral load.
Finja Schweitzer, Visa Mikkola, Monika Timmen-Wego, Björn Jensen, Gerd Fätkenheuer

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and characteristics of hepatitis B and C virus infections in treatment-naïve HIV-infected patients.
Stefan Reuter, Mark Oette, Frank Clemens Wilhelm, Bastian Beggel, Rolf Kaiser, Finja Schweitzer

Med Microbiol Immunol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition.
Sandra M Mueller, Bernd M Spriewald, Silke Bergmann, Kathrin Eismann, Melanie Leykauf, Finja Schweitzer

J Acquir Immune Defic Syndr· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates.
Jens Verheyen, Finja Schweitzer, Ellen G Harrer, Elena Knops, Sandra M Mueller

Antivir Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis